News

Home/News
News 2017-06-21T13:15:59+00:00
September 18, 2017
DelMar Pharmaceuticals Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083 for the Treatment of Ovarian Cancer
VANCOUVER, British Columbia, and MENLO PARK, Calif., Sept. 18, 2017 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the ...
September 18, 2017
Gemphire to Present at Cantor Fitzgerald Global Healthcare Conference on September 26 in New York
LIVONIA, Mich., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
September 18, 2017
Achaogen Adds Liz Bhatt as Chief Business Officer
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
September 18, 2017
Advaxis to Present at Cantor Fitzgerald Global Healthcare Conference
PRINCETON, N.J.--(BUSINESS WIRE)-- Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that Anthony Lombardo, interim ...
September 14, 2017
Transgene: First Half-Year 2017 in Line with Our Objectives: All Clinical Programs Progressing and New Collaboration Agreements Signed
Transgene (TNG.PA), a biotechnology company focused on designing and developing viral-based immune-targeted therapies, today announced its financial results for the six-month period ended June 30, ...
September 14, 2017
Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Omaveloxolone for the Treatment of Malignant Melanoma
IRVING, Texas, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced that the United ...
September 14, 2017
VBL Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference on September 26th in New York
TEL AVIV, Israel, Sept. 14, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT),  a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
September 14, 2017
World Sepsis Day 2017: CytoSorbents Sponsors the Sepsis Update 2017 Congress and Sepsis Heroes Ceremony
MONMOUTH JUNCTION, N.J., Sept. 14, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a leader in critical care immunotherapy using its CytoSorb® blood purification technology to help patients ...
September 13, 2017
Lysogene Launches World Class Clinical Advisory Board
PARIS & CAMBRIDGE, Mass.-- (BUSINESS WIRE) -- Regulatory News: Lysogene (FR0013233475 – LYS) (LYS.PA), a leading biopharmaceutical company pioneering gene therapy technologies to treat central nervous system ...
September 13, 2017
Onxeo Grants Exclusive Worldwide License of Validive® Developed for the Treatment of Oral Severe Mucositis to Monopar Therapeutics
PARIS-- (BUSINESS WIRE) -- Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or the “Company”), a clinical-stage biotechnology company specializing in the development of innovative ...
September 13, 2017
Soliqua® 100/33 provided earlier blood sugar control than insulin glargine 100 units/mL
Copenhagen, Denmark, September 13, 2017 - Sanofi has announced that in certain adults with type 2 diabetes, Soliqua® 100/33 (insulin glargine and lixisenatide injection, 100 ...
September 13, 2017
Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR in Treatment of Prader-Willi Syndrome
REDWOOD CITY, Calif., Sept. 13, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
September 13, 2017
Spring Bank to Present at the Cantor Fitzgerald Global Healthcare Conference
HOPKINTON, Mass., Sept. 13, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
September 13, 2017
Rockwell Medical Updates Progress on Calcitriol Commercial Launch
WIXOM, Mich., Sept. 13, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), today provided an update on the commercial launch of Calcitriol, stating that product ...
September 13, 2017
AIT Therapeutics’ Adjuvant Nitric Oxide Treatment Shown to be Safe and Effective in the Compassionate Use Setting in Cystic Fibrosis Patients with Non-tuberculous Mycobacteria (NTM) Infection
REHOVOT, Israel and NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical-stage anti-microbial therapeutic company treating respiratory diseases with nitric ...
September 11, 2017
DelMar Pharmaceuticals Initiates Phase 2 Clinical Trial in Newly Diagnosed MGMT-unmethylated Glioblastoma Multiforme
VANCOUVER, British Columbia and MENLO PARK, Calif., Sept. 11, 2017 /PRNewswire/ -- DelMar Pharmaceuticals (DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the development ...
September 11, 2017
Aferetica and CytoSorbents Partner to Enhance the Success of Solid Organ Transplantation
MIRANDOLA, Italy and MONMOUTH JUNCTION, N.J., Sept. 11, 2017 /PRNewswire/ -- Aferetica srl, an innovative start-up specializing in blood purification, and CytoSorbents Corporation (CTSO), a critical care immunotherapy ...
September 11, 2017
MediWound’s NexoBrid® Wins Best Poster Presentation Award at the 17th European Burns Association Congress
YAVNE, Israel, Sept. 11, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe ...
September 11, 2017
Ignyta Provides Update on Entrectinib and RXDX-105 at the ESMO 2017 Congress
SAN DIEGO -- (BUSINESS WIRE) -- Ignyta, Inc. (RXDX), a biotechnology company focused on precision medicine in oncology, today provided an update on entrectinib—an orally bioavailable, CNS-active tyrosine ...
September 11, 2017
HTG Molecular Diagnostics Provides Regulatory Update for its HTG EdgeSeq ALKPlus Assay
TUCSON, Ariz., Sept. 11, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM), a provider of instruments, reagents and services for molecular profiling applications, today ...
Page 8 of 33